Vemurafenib for BRAFV600E- positive metastatic papillary thyroid cancer

被引：3
|
作者：
Huillard, Olivier [1 ]
Tenenbaum, Florence [2 ]
Clerc, Jerome [2 ]
Goldwasser, Francois [1 ]
Groussin, Lionel [3 ]
机构：
[1] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Med Oncol, F-75014 Paris, France
[2] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Nucl Med, F-75014 Paris, France
[3] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Endocrinol, F-75014 Paris, France
来源：
LANCET ONCOLOGY | 2016年 / 17卷 / 11期
关键词：
IODINE;
D O I：
10.1016/S1470-2045(16)30499-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：E468 / E468
页数：1
相关论文
共 50 条
  • [21] The effect of BRAFV600E mutation on lymph node involvement in papillary thyroid cancer
    Sahin, Samet
    Daglar, Gul
    Menekse, Ebru
    Cavdarli, Busranur
    Baglan, Tolga
    TURKISH JOURNAL OF SURGERY, 2020, 36 (03) : 249 - 255
  • [22] Mutationally Activated BRAFV600E Elicits Papillary Thyroid Cancer in the Adult Mouse
    Charles, Roch-Philippe
    Iezza, Gioia
    Amendola, Elena
    Dankort, David
    McMahon, Martin
    CANCER RESEARCH, 2011, 71 (11) : 3863 - 3871
  • [23] Possible Involvement of BRAFV600E in Altered Gene Expression in Papillary Thyroid Cancer
    Watanabe, Reiko
    Hayashi, Yoshitaka
    Sassa, Miho
    Kikumori, Toyone
    Imai, Tsuneo
    Kiuchi, Tetsuya
    Murata, Yoshiharu
    ENDOCRINE JOURNAL, 2009, 56 (03) : 407 - 414
  • [24] Is the BRAFV600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
    Nam, Jung Kwang
    Jung, Chan Kwon
    Song, Byung Joo
    Lim, Dong Jun
    Chae, Byung Joo
    Lee, Nam Seop
    Park, Woo Chan
    Kim, Jeong Soo
    Jung, Sang Seol
    Bae, Ja Seong
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (04): : 436 - 441
  • [25] BRAFV600E Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence
    Samuel Enumah
    Abbey Fingeret
    Sareh Parangi
    Dora Dias-Santagata
    Peter M. Sadow
    Carrie C. Lubitz
    World Journal of Surgery, 2020, 44 : 2685 - 2691
  • [26] Impact of Online Tumor Board Simulation for Optimizing Testing and Treatment of Patients with BRAFV600E- mutant Metastatic Colorectal Cancer
    Kelly, M.
    Beumer, K.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S42 - S42
  • [27] Impact of Online Tumor Board Simulation for Optimizing Testing and Treatment of Patients with BRAFV600E- mutant Metastatic Colorectal Cancer
    Kelly, M.
    Beumer, K.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S42 - S42
  • [28] Interstitial lung disease associated with combination therapy of dabrafenib and trametinib in metastatic BRAFV600E- mutated poorly differentiated thyroid cancer: A case report and review of the literature
    Zeng, Qian
    Deng, Yili
    Zhang, Longdan
    Wang, Wei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (05) : 225 - 231
  • [29] Clinicopathological features and mutation of BRAFV600E in papillary thyroid carcinoma
    Suren, O.
    Malchinkhuu, M.
    Altangerel, Z.
    Dawaajargal, M.
    Munkhuu, P.
    Altanbayar, O.
    Baatarjalbuu, N.
    Bold-Erdene, A.
    Sharkhuu, E.
    Lkhagvadorj, S.
    Enkhbat, B.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S124 - S124
  • [30] Investigating an orally available small-molecule inhibitor (vemurafenib) of BRAFV600E in a novel preclinical model of human papillary thyroid cancer.
    Duquette, Mark
    Sadow, Peter M.
    Priolo, Carmen
    Fischer, Andrew
    Hodin, Richard
    Parangi, Sareh
    Lawler, Jack
    Nucera, Carmelo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345